Group 1 - The company, Hema Medical (03309.HK), announced the acquisition of 58% of the issued share capital of Hong Kong Endoscopy Examination and Treatment Centre Limited, which operates under the name "Hong Kong Endoscopy Centre" [1] - The acquisition is expected to be completed around October 2025 [1] - As of August 26, 2025, Hema Medical's stock closed at HKD 2.0, down 1.48%, with a trading volume of 1.198 million shares and a turnover of HKD 2.3911 million [1] Group 2 - Hema Medical has a market capitalization of HKD 2.531 billion, ranking 15th in the medical services sector [1] - Key financial metrics for Hema Medical compared to the industry average are as follows: - ROE: -7.51% vs. -0.96% (Industry Rank: 40) [1] - Market Capitalization: HKD 2.531 billion vs. HKD 8.349 billion (Industry Rank: 15) [1] - Revenue: HKD 1.913 billion vs. HKD 3.838 billion (Industry Rank: 16) [1] - Net Profit Margin: -5.66% vs. -850.54% (Industry Rank: 40) [1] - Gross Margin: 27.58% vs. 37.38% (Industry Rank: 32) [1] - Risk Rate: 30.52% vs. 70.69% (Industry Rank: 22) [1]
希玛医疗(03309.HK)收购一间“香港内视镜中心”